(Q84980501)
Statements
Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors for the treatment of osteoporosis (English)
Marie Wetzel
Stefan Hinsberger
Sandrine Marchais-Oberwinkler
Rolf W Hartmann
8 September 2011